Open an account

Gelteq

GELS · NASDAQ

$0.4303−$0.0046 (−1.06%)TodayMarket closed ·
Prev close $0.4349

About GELS

Gelteq Ltd. operates as a biotechnology company. The company is headquartered in Melbourne, Victoria and currently employs 7 full-time employees. The company went IPO on 2024-10-29. The firm is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The firm offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The firm also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

Employees
8
Headquarters
Melbourne, Victoria
Listed
Oct 29, 2024
Sector
Health Care
Industry
Pharmaceuticals
Website
gelteq.com

GELS key statistics

Market cap
4.61M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
73.28K
Volume
13.53K
Open price
$0.4321
High today
$0.4459
Low today
$0.4303
52 Week high
$2.01
52 Week low
$0.387

Gelteq (GELS) at a glance

Gelteq (GELS) last traded at $0.4303, with a market cap of 4.61M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.4303 and $0.4459. The current price is 0.0% above the day's low and 3.5% below its high.

Volume so far is 13.53K shares, below the average of 73.28K shares a day.

Over the past year Gelteq has ranged from $0.387 to $2.01, and now sits 3% of the way up that range.

GELS news

  • Avi Kapoor

    Nasdaq Gains Over 200 Points; US Weekly Jobless Claims Edge Higher

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • Kaustubh Bagalkote

    What's Going On With Gelteq Stock Friday?

  • Press releaseACCESS Newswire

    Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseACCESS Newswire

    Healthy Extracts Reports 2025 Net Revenue Up 45% to Record $4.5 Million

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.